MarketCap
Facebook
X
TelegramFluidigm Corporation EV/EBITDA Ratio 2011-2026 | FLDM
Annual EV/EBITDA Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -13.6 | -8.18 | -13.2 | -8.88 | -6.06 | -9.45 | -45.1 | -74.2 | -19 | -18 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.06 | -74.2 | -21.6 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 3.11 | 0.32 % | $ 101 K |  USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
-43.6 | $ 23.51 | -2.24 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 33.47 | -0.21 % | $ 360 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.49 | 1.36 % | $ 1.89 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 39.19 | 0.07 % | $ 1.09 B | USA |
 |
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 220.3 | 0.38 % | $ 161 B | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 102.42 | 0.12 % | $ 19 B | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 26.19 | -0.19 % | $ 792 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
39.5 | $ 74.41 | 0.55 % | $ 28.7 B | USA |
 |
Guardant Health
GH
|
-28.8 | $ 114.95 | 4.05 % | $ 14.1 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 20.73 | -0.34 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 111.19 | -0.83 % | $ 4.39 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 10.3 | - | $ 292 M | Israel |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
70.5 | $ 149.13 | -0.37 % | $ 23.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Lantheus Holdings
LNTH
|
-187 | $ 66.81 | 0.19 % | $ 4.62 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 232.67 | -1.19 % | $ 42.2 B | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 210.7 | -0.5 % | $ 10.8 B | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 12.4 | - | $ 1.57 B | USA |
 |
Medpace Holdings
MEDP
|
30.7 | $ 589.18 | -0.66 % | $ 18.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 185.86 | 1.94 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
-4.25 | $ 9.78 | 1.24 % | $ 1.27 B | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
-1.8 | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 272.1 | 0.85 % | $ 22.8 B | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 388.7 | -0.3 % | $ 29.5 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
38 | $ 184.66 | -0.66 % | $ 15.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 680.0 | 0.49 % | $ 56.1 B | USA |
 |
Personalis
PSNL
|
-7.07 | $ 9.82 | -1.55 % | $ 582 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.82 | -1.47 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
27.4 | $ 133.03 | -0.16 % | $ 40.4 B | USA |
 |
Biomerica
BMRA
|
-6.24 | $ 2.35 | -1.67 % | $ 5.4 M | USA |